Acute Pneumonia and Its Complications


Acknowledgment

The authors acknowledge previous contributions of Dennis Murray and Chitra Mani to this chapter.

Pneumonia , a Greek word meaning “inflammation of the lungs,” is the most common cause of morbidity and mortality in infants and children due to infection worldwide.

Acute Pneumonia

Pneumonia is a lower respiratory tract disease usually caused by an infectious agent resulting in inflammation of the tissues of one or both lungs. The burden of pneumonia in developing countries is >150 million new cases and resulting in >1.3 million preventable deaths each year. , , Morbidity and mortality rates for community-acquired pneumonia (CAP) among children in the US is considerably less. Outpatient pediatric visit rates for CAP in the US range 16.9–22.4 per 1000 children overall, with 32.3–49.6 cases per 1000 in children 1–5 years of age. The annual incidence of hospitalization for CAP was 15.7 cases per 10,000 cases in a prospective, population-based multicenter study. In 2007, the overall mortality for acute pneumonia in US children was ≤2%, depending on factors including age, race, socioeconomic status and geographic region.

Epidemiology

In the US, lower respiratory infections (LRIs) occur throughout the year but excessively during the fall and winter when children are confined indoors, resulting in more efficient spread of the infections by contact or droplet transmission. Myriad factors predispose to acquisition of LRI: childcare and school attendance, indoor crowding, passive exposure to smoke, underimmunization, alcohol abuse in adolescents causing aspiration pneumonia, and underlying medical conditions such as low birth weight, bronchopulmonary dysplasia, asthma, heart disease, seizures, neuromuscular illness, gastroesophageal reflux disease, malnutrition, immunocompromised state, sickle cell disease, and cystic fibrosis. , Additional risk factors associated with pneumonia in children <5 years of age include frequent upper respiratory tract infections (URIs) ( >3 episodes in 12 months), wheezing at any age, and history of otitis media requiring tympanostomy tube placement before 2 years of age. Risk factors for pneumonia in children >5 years of age include wheezing at any age and ≥3 episodes of URI within 12 months.

Etiologic Agents

Viruses and bacteria cause most LRIs in infants and children. The true prevalence of the pathogens causing LRI is uncertain because microbial etiology is ascertained infrequently, owing to difficulty in differentiating infection from colonization and lack of dependable diagnostic laboratory tests. In two studies of immunocompetent children with pneumonia, specific etiologic agents were confirmed in only 43%–66%. , Some cases have more than one pathogen identified, making assigning etiology difficult. In a large multicenter study of children hospitalized for pneumonia who had specimens available for evaluation, a likely etiologic agent was detected in 81%, with >1 viruses in 66%, bacteria in 8%, and both bacterial and viral pathogens in 7% of cases. Confirmation of causative bacteria can be aided by blood cultures, but these are positive in only 1%–10% of hospitalized children with presumed bacterial pneumonia. , , Etiologic agents causing pneumonia vary by age, underlying illness, maturity, and condition of the immune system. In most cases of acute pneumonia, extensive invasive testing is not warranted. Epidemiologic information frequently is useful in guiding differential diagnosis and management (see Chapter 21 ). Certain pathogens, particularly respiratory syncytial virus (RSV), rhinoviruses, influenza viruses, and Mycoplasma, are seasonal. In other instances, the pattern of family illness provides a clue to causative nonbacterial agents.

For purposes of management, the relative importance of etiologic agents in a series of patients who have been extensively evaluated is extrapolated to patients with similar clinical syndromes, physical findings, and laboratory results. Table 34.1 lists the common etiologic agents of acute pneumonia in children.

TABLE 34.1
Microbial Causes of Community-Acquired Pneumonia in Childhood
Age Etiologic Agents a Clinical Features
Birth–3 wk Group B Streptococcus Part of early-onset septicemia; usually severe
Gram-negative enteric bacilli Frequently nosocomial; occurs infrequently within 1 week of birth
Cytomegalovirus Part of systemic cytomegalovirus infection
Listeria monocytogenes Part of early-onset septicemia
Herpes simplex virus Part of disseminated infection
Treponema pallidum Part of congenital syndrome
Genital Mycoplasma or Ureaplasma From maternal genital infection; afebrile pneumonia
3 wk–3 mo Chlamydia trachomatis From maternal genital infection; afebrile, subacute, interstitial pneumonia
Respiratory syncytial virus (RSV) Peak incidence at 2–7 months of age; usually wheezing illness (bronchiolitis/pneumonia)
Parainfluenza viruses (PIV), especially type 3 Similar to RSV, but in slightly older infants and not epidemic in the winter
Streptococcus pneumoniae The most common cause of bacterial pneumonia
Bordetella pertussis Primarily causes bronchitis; secondary bacterial pneumonia and pulmonary hypertension can complicate severe cases
3 mo–5 yr RSV, PIV, influenza, hMPV, adenovirus, rhinovirus Most common causes of pneumonia
Streptococcus pneumoniae Most common cause of lobar pneumonia despite decreasing incidence after vaccine use
Haemophilus influenzae Type b uncommon with vaccine use; nontypable stains cause pneumonia in immunocompromised hosts, as part of polymicrobial aspiration pneumonia, and in resource-poor countries
Staphylococcus aureus Uncommon, but pneumonia due to CA-MRSA and MSSA occurs
Mycoplasma pneumoniae Causes pneumonia primarily in children >4 yr
Mycobacterium tuberculosis Major concern in areas of high prevalence, exposure to people from endemic countries and in children with HIV
5–15 yr Mycoplasma pneumoniae Major cause of pneumonia; radiographic appearance variable
Chlamydophila pneumoniae Controversial, but probably an important cause in adolescents
CA-MRSA, community-acquired methicillin-resistant Staphylococcus aureus ; MSSA, methicillin-susceptible S. aureus ; HIV, human immunodeficiency virus; hMPV, human metapneumovirus.

a Ranked roughly in order of frequency. Uncommon causes with no age preference: enteroviruses (echovirus, coxsackievirus), mumps virus, Epstein-Barr virus, Hantavirus, Neisseria meningitidis (often group Y), anaerobic bacteria, Klebsiella pneumoniae , Francisella tularensis , Coxiella burnetii , and Chlamydia psittaci . Streptococcus pyogenes occurs sporadically or especially associated with varicella-zoster virus infection.

Pathogens in Neonates and Young Infants

Pneumonia in neonates can manifest as early-onset infection (within 3 days of life) or late-onset infection (after 3 days of life). Most early-onset infections are caused by organisms acquired from the maternal genital tract through aspiration of contaminated amniotic fluid or genital tract secretions. Group B Streptococcus (GBS) is the most frequent cause of early-onset pneumonia. Early-onset infection due to GBS, Listeria monocytogenes , Escherichia coli , and other gram-negative bacilli can cause severe respiratory distress resembling surfactant deficiency and usually is part of a widespread systemic infection. Prenatal and perinatal risk factors, including preterm delivery, maternal chorioamnionitis, rupture of membranes >18 hours, and lack of intrapartum chemoprophylaxis for maternal GBS colonization, increase the risk for neonatal pneumonia. Hematogenous dissemination can occur occasionally from an infected mother.

Pneumonia due to Chlamydia trachomatis acquired perinatally can become symptomatic 2–3 weeks after birth, and characteristically the infant is afebrile. Bordetella pertussis infection in very young infants can have severe complications of apnea, bronchopneumonia, or pulmonary hypertension. With wide availability of extended panels for detection of respiratory pathogens by rapid molecular testing, viruses are increasingly confirmed as important causes of pneumonia in young infants. Severe, often fatal pneumonia also can be the result of disseminated herpes simplex virus (HSV) infection in neonates. Congenital cytomegalovirus (CMV) and Treponema pallidum are recognized but less common causes of neonatal pneumonia . Genital Mycoplasma and Ureaplasma spp. are purported causes of LRI, especially in very-low-birth-weight infants.

Pathogens in Infants, Children, and Adolescents

In a recent study determining the etiologic agents for CAP in children <18 years of age, viruses accounted for 66%, bacteria for 8%, and mixed infection for 7% of cases. This study also noted that viral pneumonia was more common in children <2 years of age compared with older children, whereas Mycoplasma was more common in children >5 years of age (19%) compared with younger children (3%).

Viruses

Overall, viruses account for approximately 73% of CAP in childhood. However, when categorized by age, viruses accounted for >80% of CAP in children <2 years compared with 49% in those >2 years of age. RSV is the predominant viral pathogen of childhood pneumonia, accounting for 28%, with highest incidence in children <2 years of age. Other viruses include human metapneumovirus (hMPV), parainfluenza viruses (types 1, 2, and 3), influenza viruses (A and B), adenoviruses, bocavirus, rhinoviruses, and enteroviruses. Rhinoviruses have been recovered from culture in 22%–27% of cases of childhood pneumonia. Although influenza, RSV, SARS-CoV-2 and hMPV are significantly associated with CAP in children, the roles of other viruses such as parainfluenza viruses, enteroviruses, rhinoviruses, endemic coronaviruses, and bocavirus are difficult to ascribe owing to dual virus detections in illness, detections in well children, and extended durations of shedding. In a case-control study, endemic coronaviruses and bocavirus were negatively associated with CAP. Although SARS-CoV-2 in general causes mild illness in children, it has a reported case fatality rate greater than that of influenza pneumonia in children. , LRI due to varicella-zoster virus (VZV), CMV, and HSV largely is limited to immunocompromised or very young immune-naïve children. Cases of LRI due to human parechoviruses (HPeV types 1–4) have been reported, but serious cases of illness appear to be rare. LRIs due to viruses mirror general seasonality of specific viruses: RSV, hMPV, influenza (winter), parainfluenza (spring and autumn), and rhinoviruses and adenoviruses (throughout the year).

Mycoplasma pneumoniae and Chlamydophila pneumoniae

LRI due to Mycoplasma pneumoniae affects school-aged children predominantly; molecular detection in upper respiratory tract secretions in younger children has less clear meaning. Coinfections with either Streptococcus pneumoniae (30%) or Chlamydophila pneumoniae (15%) occurs. Infections due to M. pneumoniae occur in 2-to 4-year cycles. Unlike respiratory viruses, transmission of M. pneumoniae among family members is slow, with a median interval of 3 weeks (compared with <1 week for common viruses) between cases. Pneumonia is rarely ascribed to C. pneumoniae in children in the US compared with European and Asian countries and is associated with reactive airway disease or asthma in children >5 years of age. Asymptomatic carriage of C. pneumoniae is well documented and confounds assessment of pathogenicity.

Bacteria

Bacterial pneumonia is more common in children living in resource-poor countries, related to several factors, including chronic malnutrition, crowding, inadequate vaccination, and constant exposure to biomass fuels without adequate ventilation. Various tests that determine bacterial products in blood, respiratory tract secretions, and urine have been used in an attempt to assign a causative role in LRI but are positive in <10% of cases. , , Evidence from multiple sources indicates that S. pneumoniae is the single-most common cause of bacterial pneumonia beyond the first few weeks of life, causing >76% of cases of bacterial pneumonia. , , Pneumococcal serotypes causing uncomplicated pneumonia in the US generally are similar to those that cause bacteremia and other invasive pneumococcal disease (IPD) or acute otitis media (see Chapter 123 ). In the years following introduction of the pneumococcal conjugate vaccines (PCV7 in 2000 and PCV13 in 2010), IPD declined dramatically in vaccinated children and in older persons through indirect effect. In the PCV13 era, IPD, including cases of pneumonia are diagnosed increasingly in older children with underlying medical conditions. Pneumococcal pneumonia occurs in all age groups, but especially in those <2 years of age.

In countries with widespread immunization with the Hib conjugate vaccine, the frequency of Haemophilus influenzae type b (Hib) infection, including pneumonia, has plummeted. Pneumonia due to non–type B and nontypable H. influenzae is uncommon in otherwise healthy children in the US, except in premature infants and in children with underlying chronic conditions or diseases or with hospital-associated pneumonia. Acute pneumonia and necrotizing pneumonia in children can be caused by methicillin-susceptible Staphylococcus aureus (MSSA) and community-associated methicillin-resistant S. aureus (CA-MRSA), especially carrying virulence factors like Panton-Valentine leukocidin. Streptococcus pyogenes (group A Streptococcus ) is not a frequent cause of acute pneumonia but can cause rapidly progressive and severe pneumonia, frequently leading to hypoxemia and pleural effusion within hours of onset. Other bacteria, especially gram-negative organisms, are rare causes of pneumonia in previously healthy children but can cause LRI in prematurely born and term neonates, technologically dependent infants and children, and patients with cystic fibrosis, sickle cell disease, primary or acquired immune deficiency, or immune suppression.

Other Pathogens

A variety of epidemiologic and host factors prompt consideration of specific organisms ( Table 34.2 ). The most important of these is tuberculosis, which should always be suspected if there is a history of exposure, if hilar adenopathy is present, or when pneumonia does not respond to usual therapy. In North America and Europe, primary tuberculosis pneumonia occurs predominantly in children born to or in contact with recent immigrants from countries where tuberculosis is endemic, after contact with infected adults, or in HIV-infected children.

TABLE 34.2
Consideration of Etiologic Agents of Pneumonia in Special Circumstances
Organism Risk Factors Diagnostic Methods
Histoplasma capsulatum Exposure in certain geographic areas (Ohio and Mississippi river valleys, Caribbean) Culture of respiratory tract secretions; urine antigen test; serum immunodiffusion antibody test; and serum Histoplasma complement fixation antibody test
Coccidioides immitis Exposure in certain geographic areas (southwestern United States, Mexico, and Central America) Culture of respiratory tract secretions; serum immunodiffusion antibody test
Blastomyces dermatitidis Exposure in certain geographic areas (Ohio, Mississippi, St. Lawrence river valleys) Culture of respiratory tract secretions; serum immunodiffusion antibody test
Legionella pneumophila Exposure to contaminated water supply Culture or direct fluorescent assay of respiratory tract secretions; urine antigen test
Francisella tularensis Exposure to infected animals, usually rabbits Acute and convalescent serology
Pseudomonas pseudomallei (melioidosis) Travel to rural areas of Southeast Asia Culture of respiratory tract secretions; acute and convalescent serology
Brucella abortus Exposure to infected goats, cattle, or their products of conception; ingestion of unpasteurized milk Acute and convalescent serology
Leptospira spp. Exposure to urine of infected dogs, rats, or swine, or to water contaminated by their urine Culture of urine; acute and convalescent serology
Chlamydia psittaci Exposure to certain infected birds (often parakeets) Acute and convalescent serology
Coxiella burnetii Exposure to infected sheep Acute and convalescent serology
Hantavirus Exposure to dried mouse dung in a closed structure (opening cabins after winter closure) Acute and convalescent serology; PCR test on the respiratory tract secretions
PCR, polymerase chain reaction.

Having resided in or traveled to certain geographic areas raises concern for special pathogens. Coccidioides immitis is endemic in the southwestern US, northern Mexico, and parts of Central and South America. Histoplasma capsulatum is endemic in the eastern and central US and Canada. Chlamydia psittaci and Coxiella burnetii are transmitted from infected birds, animals, or humans. Pneumocystis jirovecii causes pneumonia in unrecognized HIV-infected infants at 3–6 months of age, in severely malnourished children, and in other immunocompromised or immunosuppressed hosts not receiving prophylaxis. Legionella pneumophila is a rare cause of pneumonia in children, affecting older or immunocompromised children after certain water-associated environmental exposures.

Pathogenesis and Pathology

Pneumonia occurs when a host susceptible to a pathogen is exposed to a high-density aerosol inoculum, has a compromised systemic or secretory immunity, or has an impaired clearance mechanism. , Most patients with pneumonia have initial colonization or infection of the upper respiratory tract. Invasion of the lower respiratory tract usually occurs when normal defense mechanisms are impaired, such as associated with a viral infection, chronic malnutrition, chronic aspiration, impaired cough reflex (e.g., after sedation, neurologic damage, intubation), or after exposure to environmental pollutants. Bacterial pneumonia occasionally occurs by the hematogenous route. In the early stages of lobar or bacterial pneumonia, protein-rich edema fluid containing numerous organisms fill the alveoli, leading to marked capillary congestion and causing neutrophil exudation and intra-alveolar hemorrhage. There is decrease in lung compliance, increase in pulmonary resistance, small airway obstruction, air trapping, and change in ventilation-perfusion ratio, all leading to the clinical signs of respiratory distress.

Defense mechanisms against LRI consist of (1) anatomic and physiologic barriers; (2) humoral and cell-mediated protection; and (3) phagocytic activity. The presence of hairs in the anterior nares (that trap particles >10 μm in size), configuration of the nasal turbinates, and acute branching of airways form protective anatomic barriers. Filtration and humidification capacities of the upper airways, mucus production, and middle airway protection by the epiglottis and cough reflex (eliminating particles 2–10 μm) form physiologic barriers. The mucociliary blanket transports microscopic amounts of normally aspirated oropharyngeal flora and particulate matter up the tracheobronchial tree, minimizing the presence of bacteria below the carina. Particles <1 μm can escape into the lower airways. Immunoglobulin A (IgA) antibody is secreted into the upper airways, and IgG and IgM leach from the local capillaries into the lower airways. Alveolar fluid surfactant, fibronectin, complement, lysozyme, and iron-binding proteins also have antimicrobial activity. The lower respiratory tract has three distinct populations of macrophages: alveolar, interstitial, and intravascular macrophages. Alveolar macrophages are the preeminent phagocytic cells that ingest and kill bacteria. In addition to phagocytic function, interstitial macrophages are antigen-processing cells, whereas the intravascular macrophages clear inflammatory debris through the bloodstream. Viral infection (especially due to influenza virus), high oxygen concentration, uremia, and use of alcohol or drugs can impair function of alveolar macrophages, predisposing to pneumonia. Cell-mediated immunologic mechanisms play an important role in pulmonary infections caused by viruses, and intracellular organisms such as Mycobacterium tuberculosis and Legionella that survive within pulmonary macrophages.

Viral Pneumonia

Viral pulmonary infections follow three pathologic patterns: bronchiolitis, interstitial pneumonia, and parenchymal infection. The first two patterns often overlap. , Viral pneumonia is characterized by neutrophilic infiltration of the lumen of the airway with lymphocytic infiltration of the interstitium and parenchyma of the lungs. Giant cell formation and viral inclusions within the nucleus of the respiratory cells are histologically evident in many viral infections, including those caused by adenovirus, measles, varicella, CMV, and Epstein-Barr virus, especially in children with immune deficiency. Air trapping with disturbances in ventilation-perfusion ratio occur when obstructed or obliterated small airways and thickened septa impede oxygen diffusion. Necrosis of bronchial or bronchiolar epithelium occurs in severe, sometimes fatal, viral infections (e.g., adenovirus infection). Certain viruses, especially pandemic-09 influenza H1N1 and SARS-CoV-2, can elicit aberrant innate immune responses that lead to acute respiratory distress syndromes (ARDS).

Bacterial Pneumonia

Bacterial pneumonia can follow five pathologic patterns: (1) parenchymal infection, inflammation, and consolidation of a lobe or a segment of a lobe (i.e., lobar pneumonia, the classical pattern of S. pneumoniae ); (2) primary infection of the airways and surrounding interstitium (bronchopneumonia, often due to S. pyogenes and S. aureus ); (3) necrotizing parenchymal pneumonia that occurs after aspiration of anaerobes or with certain S. aureus or S. pneumoniae ; (4) caseating granulomatous disease due to M. tuberculosis ; and (5) peribronchial and interstitial disease with secondary parenchymal infiltration, which can occur when viral pneumonia is complicated by bacterial infection. In bacterial pneumonia, airspaces become filled with transudates and neutrophilic exudates, impairing oxygen diffusion. The proximity of the infected alveoli to the rich pulmonary vascular bed increases the risk for bacteremia, septicemia, or shock.

Clinical Manifestations

The symptoms of pneumonia are varied and nonspecific and may be subtle depending on several factors, including the etiologic agents, age of the host, inoculum size, and individual’s immune response (see Chapter 21 ). Acute onset of fever, cough, and tachypnea are classic. Fever can be absent in very young infants with C. trachomatis , B. pertussis , or Ureaplasma infection . Infants can manifest only poor feeding and fussiness. Children <5 years of age often have a prodrome of low-grade fever and rhinorrhea due to a viral URI before developing lower respiratory tract symptoms. Fever and rapid breathing can precede onset of cough in some children. Older children can complain of pleuritic chest pain or nuchal rigidity (each referable to the lobe involved). Signs of respiratory distress include tachypnea, hypoxemia (oxygen saturation <92%), apnea, increased work of breathing (subcostal, intercostal or suprasternal retractions; nasal flaring; or grunting) or altered mental status. Guidelines developed by the World Health Organization (WHO) for the clinical diagnosis of pneumonia in resource-limited countries highlight tachypnea and retractions as the two best indicators of LRI. Tachypnea is defined as >50 breaths/min in infants <12 months, >40 for those 1–5 years, and >30 for children >5 years of age. Among children <5 years of age, tachypnea (as defined by WHO) had the highest sensitivity (74%) and specificity (67%) for radiologically confirmed pneumonia but was less sensitive and specific early in the course of illness. , Tachypnea can occur with other conditions, such as fever, asthma, cardiac disease, and metabolic acidosis. The predictive values of clinical findings for pneumonia have been studied repeatedly. In one study, the combination of a respiratory rate >50 breaths/min, oxygen saturation <96%, and the presence of nasal flaring in children <12 months of age was highly associated with radiographically confirmed pneumonia. Oxygen saturation frequently is decreased with moderate to severe pneumonia and is an indication for hospital admission. , An hypoxemic infant or child may not appear cyanotic. Although hypoxemia, use of accessory muscles of respiration, head bobbing, nasal flaring, and grunting are predictive of pneumonia, their absence does not exclude pneumonia. , Decreased and bronchial breath sounds, egophony (“E” to “A” change), bronchophony, tactile fremitus, and dullness to percussion are specific signs of lung consolidation. Crackles heard upon auscultation are the hallmark of pneumonia but can be present due to noninfectious fluid and can be absent in a dehydrated patient. Isolated wheezing or prolonged expiration is associated with bronchiolitis and is uncommon in bacterial pneumonia. Almost three-fourths of children with radiographically confirmed pneumonia appear ill. Severity of illness correlates with the likelihood of a bacterial cause. Additionally, approximately 6%–25% of children <5 years of age with body temperature >39°C and a white blood cell (WBC) count >20,000/μL without an alternative source of major infection and with no symptoms or signs of lower respiratory tract disease have radiographically confirmed pneumonia.

In one study determining the interobserver agreement of signs of pneumonia, there was more observer agreement with clinical signs (respiratory rate and cyanosis) compared with retractions or auscultatory signs (crackles and wheezing) of pneumonia. Unfortunately, neither respiratory rate nor cyanosis is a sensitive or specific indicator of hypoxia. Oxygen saturation should be measured in any child with respiratory distress.

Neonates and Young Infants

The neonate with bacterial infection due to GBS, L. monocytogenes, or gram-negative bacilli usually manifests with respiratory distress in the first few hours of life. Septicemia and infection at other sites can dominate the clinical presentation. Pneumonia in children <2 months of age usually is characterized by tachypnea (respiratory rate >60 breaths/min), intercostal retractions, or both. In very young infants, particularly those who are born prematurely, fever can be absent, and apneic spells can be the prominent initial finding. C. trachomatis pneumonia in infants is insidious, with infants coming to attention at 3–12 weeks with staccato cough, tachypnea, and crackles in absence of fever or distress. Wheezing is uncommon. Eosinophilia and elevated total serum IgM concentration can be present. ,

Infants, Children, and Adolescents

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here